9:36
Video
Metabolic Health Meets Oncology: GLP-1 Receptor Agonists in Breast Cancer
As GLP-1 receptor agonists surge in popularity for obesity and diabetes, how do they actually impact breast cancer biology, treatment…
Latest
All posts- PostBridging the Regulatory Gap: Operationalizing Quality Frameworks in Oncology Real-World Data
- PostA New Milestone for the AI-Powered Cancer Vaccine
- PostReimagining Oncology Education With Human-Guided AI
- PostBringing Bispecific Antibodies Into Community Myeloma Care
- PostBeyond the Headlines: AI’s Growing Role in Breast Oncology
Free CME
All coursesPalliative Care Myths: Sorting Fact From Misconception
0.25 AMA PRA Category 1 Credit™
Expires Aug 26, 2027
CME
Start Transitions: Hospice, Comfort-Focused Care, and Bereavement
0.25 AMA PRA Category 1 Credit™
Expires Aug 26, 2027
CME
Start Screen and Evaluate: Making Cancer-Related Fatigue Visible
0.25 AMA PRA Category 1 Credit™
Expires Aug 26, 2027
CME
Start The Exercise Prescription: What the Evidence Says
0.25 AMA PRA Category 1 Credit™
Expires Aug 26, 2027
CME
Start News
More news- The oncologistClinical Endpoints in Trials of Metastasis-Directed Therapy in Oligometastatic Cancer: A Systematic Review and Surrogacy Analysis
- The oncologistIntegrating ctDNA-Based ESR1m Monitoring Into First-Line Care for ER+, HER2- Advanced Breast Cancer: A Consensus Workflow
- Epidemiology and Psychiatric SciencesPost-traumatic stress in cancer patients: prevalence and psychosocial correlates
- International journal of urology : official journal of the Japanese Urological AssociationFactors Associated With Trifecta and Pentafecta Achievement in Robot-Assisted Laparoscopic Partial Nephrectomy for Highly Complex Renal Tumors
Videos
All videos
Posts
All posts
Making the Match: How AI Improves Clinical Trial Matching
Expert Perspectives
5 min read
New Paths Forward in Cutaneous T-Cell Lymphoma
Expert Perspectives
8 min read
Building Trust in Real-World Evidence With AI and High-Quality Data
Expert Perspectives
7 min read
Immunotherapy Fatigue: Resistance, Retreatment, and When to Stop
Expert Perspectives
6 min read
Additional Advances in Metastatic Prostate Cancer Research and Treatment
Expert Perspectives
4 min read
Additional Advances in Extrapulmonary Neuroendocrine Carcinomas
Expert Perspectives
6 min read